TSH抑制加重动脉炎症:甲状腺癌患者18F-FDG PET研究
TSH抑制期血管TBRmax呈升高趋势(全血管1.6对1.8,p=0.058),CRP升高(2.9对4.8 mg/l,p=0.005),提示TSH抑制期间动脉炎症增加。
要点
- TSH抑制期全血管TBRmax呈升高趋势(1.6对1.8,p=0.058)。
- 左甲状腺素治疗后CRP升高(2.9对4.8 mg/l,p=0.005)。
- 与甲功正常对照相比,TSH抑制期颈动脉等部位TBR显著更高。
核心结论
- TSH抑制期间动脉炎症增加,可能解释TSH抑制患者心血管疾病风险升高的机制。
研究设计与样本
- 分析颈动脉、主动脉弓、升主动脉、降主动脉和腹主动脉的FDG摄取,计算经血池校正的TBR。
- 结果与甲功正常的历史对照者进行比较。
主要发现
- TSH抑制期全血管TBRmax呈升高趋势(1.6对1.8,p=0.058)。
- 左甲状腺素治疗后CRP升高(2.9对4.8 mg/l,p=0.005)。
- 与甲功正常对照相比,TSH抑制期颈动脉、主动脉弓、胸降主动脉及全血管合并的TBRmax显著更高(p=0.013、p=0.016、p=0.030、p=0.018)。
临床怎么用
- 甲状腺癌患者TSH抑制治疗期间应关注动脉炎症及心血管风险。
- 18F-FDG PET/CT可用于评估TSH抑制对血管炎症的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We aimed to investigate the influence of both hypothyroidism and thyroid-stimulating hormone (TSH) suppression on vascular inflammation, as assessed with 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT). METHODS: Ten thyroid carcinoma patients underwent an 18F-FDG PET/CT during post-thyroidectomy hypothyroidism and during thyrotropin (TSH) suppression after 131I (radioiodine) ablation therapy. We analysed the 18F-FDG uptake in the carotids, aortic arch, ascending, descending, and abdominal aorta to investigate the effects of thyroid hormone status on arterial inflammation. Target-to-background ratios (TBRs) corrected for blood pool activity were established for all arterial territories. Results were further compared to euthyroid historic control subjects. RESULTS: In general, there was a trend towards higher vascular TBRs during TSH suppression than during hypothyroidism (TBRmax all vessels = 1.6 and 1.8, respectively, p = 0.058), suggesting a higher degree of arterial inflammation. In concurrence with this, we found increased C-reactive protein (CRP) levels after levothyroxine treatment (CRP = 2.9 mg/l and 4.8 mg/l, p = 0.005). An exploratory comparison with euthyroid controls showed significant higher TBRs during TSH suppression for the carotids, aortic arch, thoracic descending aorta, and when all vascular territories were combined (TBRmaxp = 0.013, p = 0.016, p = 0.030 and p = 0.018 respectively). CONCLUSIONS: Arterial inflammation is increased during TSH suppression. This finding sheds new light on the underlying mechanism of the suspected increased risk of cardiovascular disease in patients with TSH suppression.
引用
- Boswijk E, Sanders KJC, Broeders EPM, et al. TSH suppression aggravates arterial inflammation - an 18F-FDG PET study in thyroid carcinoma patients. Eur J Nucl Med Mol Imaging. 2019. PMID: 30859432. doi:10.1007/s00259-019-04292-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。